Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reuters raises PTSC component rating

Reuters raises PTSC component rating

posted on Oct 28, 2008 10:54AM

Reuters has a rating system that uses 4 components to calculate a weighted "Overall Investment rating".

PTSC’s overall rating has not changed, it remains the highest they have, Outperform. "Outperform" designates the companies that rank in the top 30% of companies covered.

Within the past few weeks 1 of the 4 components (Operational Trends) changed from a rating of Neutral to now rated Outperform.

The 4 component’s ratings and their % weighting factor are:

Fundamental Quality = Outperform 36%

Technical Factors = Underperform 27% (lowest rating)

Operational Trends = Outperform 13%

Value Catch-up = Outperform 24%

Note:

Technical Factors = SP trend,

Operational Factors = Sales & EPS growth.

Share
New Message
Please login to post a reply